Use of bromfenac 0.09% (Broksinak) in the complex therapy for HLA-B27-associated anterior uveitis
Background: There is still no consensus among ophthalmologists as to whether the prolonged use of topical bromfenac 0.09% is feasible in therapy for acute uveitis. Purpose: To improve the efficacy of treatment of HLA-B27-associated anterior uveitis through the use of Broksinak (containing bromfenac...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Ukrainian Society of Ophthalmologists,
2024-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |